In June 2007, the Bombay Stock Exchange had approached the Forward Markets Commission , the commodities market watchdog, for buying 26 per cent stake in NMCE. The valuation for the stake sale to BSE is not known, but the new capital infusion with a premium is expected to be around Rs 100 crore. A senior BSE official, who did not wish to be identified, declined to comment on the value of the deal.